Published in Ann R Coll Surg Engl on November 01, 1977
The Hunterian Oration for 1871. Br Med J (1871) 1.57
Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology (1997) 2.85
Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol (1996) 2.22
Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol (1976) 1.93
Human amnion as an adjunct in wound healing. Lancet (1980) 1.92
Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol (2000) 1.80
Synaptic biochemistry of amino acids. Fed Proc (1973) 1.74
Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency. Nature (1976) 1.71
Isolation and some properties of macrophage alpha-actinin: evidence that it is not an actin gelling protein. Biochemistry (1984) 1.61
Clinical correlates of sleep benefit in Parkinson's disease. Neurology (1997) 1.58
Use of cytochalasin B to distinguish between early and late events in neutrophil activation. Biochim Biophys Acta (1980) 1.56
Rat mast cells permeabilized with ATP secrete histamine in response to calcium ions buffered in the micromolar range. J Physiol (1981) 1.52
Treatment of chronic ulceration of the legs with human amnion. Lancet (1980) 1.51
Stimulus-secretion coupling in rabbit neutrophils is not mediated by phosphatidylinositol breakdown. Nature (1980) 1.47
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta (1997) 1.44
The dependence on Ca2+ of phosphatidylinositol breakdown and enzyme secretion in rabbit neutrophils stimulated by formylmethionyl-leucylphenylalanine or ionomycin. Biochem J (1981) 1.41
Ionomycin stimulates mast cell histamine secretion by forming a lipid-soluble calcium complex. Nature (1980) 1.31
Neurotransmitter receptors in the brain: biochemical identification. Annu Rev Physiol (1976) 1.30
The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta (1999) 1.23
f-MetLeuPhe-induced phosphatidylinositol turnover in rabbit neutrophils is dependent on extracellular calcium. FEBS Lett (1980) 1.21
Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol (2000) 1.20
An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev (1999) 1.17
From noli-me-tangere to rodent ulcer: the recognition of basal cell carcinoma. Br J Plast Surg (1974) 1.14
Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors. Brain Res Dev Brain Res (1996) 1.12
Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol (1998) 1.09
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group. Neurology (1997) 1.08
Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem (2001) 1.06
Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann Neurol (1998) 1.04
Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion. J Neurochem (1998) 1.01
Inhibitory effects of natural flavonoids on secretion from mast cells and neutrophils. Arzneimittelforschung (1981) 1.00
Loss of cell surface microvilli on rat basophilic leukaemia cells precedes secretion and can be mimicked using the calmodulin antagonist trifluoperazine. Inflamm Res (1997) 0.98
Freeze-fracture studies of chemotactic peptide-induced exocytosis in neutrophils: evidence for two patterns of secretory granule fusion. J Ultrastruct Res (1983) 0.98
Specific glycine--accumulating synaptosomes in the spinal cord of rats. Proc Natl Acad Sci U S A (1972) 0.97
Neurochemical correlates of synaptically active amino acids. Life Sci (1974) 0.97
Degranulation of individual mast cells in response to Ca2+ and guanine nucleotides: an all-or-none event. J Cell Biol (1993) 0.97
Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration (1996) 0.97
Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. J Neurochem (2000) 0.96
Characterization and time course of MPP+ -induced apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res (1999) 0.96
Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem (2000) 0.96
Visualization of cyclosporin A and Ca2+-sensitive cyclical mitochondrial depolarizations in cell culture. Biochim Biophys Acta (1999) 0.96
Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res (1991) 0.95
Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors. Brain Res (1975) 0.95
Angiotensin II binding to mammalian brain membranes. J Biol Chem (1976) 0.95
Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis. Brain Res Dev Brain Res (1991) 0.95
The long-term results of the use of human amnion in the treatment of leg ulcers. Br J Plast Surg (1984) 0.94
The bacterial factors which stimulate neutrophils may be derived from procaryote signal peptides. FEBS Lett (1980) 0.94
The healing of chronic venous leg ulcers with prepared human amnion. Br J Plast Surg (1989) 0.94
Plasma-membrane location of phosphatidylinositol hydrolysis in rabbit neutrophils stimulated with formylmethionyl-leucylphenylalanine. Biochem J (1982) 0.93
Amino acid neurotransmitter candidates: sodium-dependent high-affinity uptake by unique synaptosomal fractions. Science (1972) 0.92
Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Res (2001) 0.92
Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes. Brain Res (1977) 0.91
Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem Biophys Res Commun (1998) 0.90
Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. J Neurosci Res (2000) 0.89
Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model. Prog Neuropsychopharmacol (1977) 0.89
Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers. Brain Res Dev Brain Res (1990) 0.89
The alpha-thalassemias. Ann N Y Acad Sci (1990) 0.88
Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors. Gene Ther (2011) 0.88
A review of the role of amniotic membranes in surgical practice. Obstet Gynecol Annu (1982) 0.87
Alterations of brain neurotransmitter receptor binding in Huntington's chorea. Brain Res (1976) 0.87
Circular ruffle formation in rat basophilic leukemia cells in response to antigen stimulation. Eur J Cell Biol (1997) 0.86
Maternal inheritance in Parkinson's disease. Ann Neurol (1997) 0.86
Early events in the activation of Ca2+ dependent secretion: studies with rat peritoneal mast cells. J Physiol (Paris) (1980) 0.86
Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function. Brain Res Dev Brain Res (1990) 0.85
Mechanisms of granule enzyme secretion from permeabilized guinea pig eosinophils. Dependence on Ca2+ and guanine nucleotides. J Immunol (1991) 0.84
Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues. Eur J Pharmacol (1980) 0.84
L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity? Neuroreport (1994) 0.84
The phospholipid headgroup specificity of an ATP-dependent calcium pump. Biochim Biophys Acta (1978) 0.84
Evidence that spinal interneurons undergo programmed cell death postnatally in the rat. Eur J Neurosci (1997) 0.84
Peripheral-type benzodiazepine receptors in human glioblastomas: pharmacologic characterization and photoaffinity labeling of ligand recognition site. Brain Res (1990) 0.84
The induction of ovulation in the squirrel monkey (Saimiri sciureus) with pregnant mares serum (PMS) and human chorionic gonadotrophin (HCG). J Reprod Fertil (1967) 0.84
Development of striatal dopaminergic function. III: Pre- and postnatal development of striatal and cortical mRNAs for the neurotrophin receptors trkBTK+ and trkC and their regulation by synaptic dopamine. Brain Res Dev Brain Res (1996) 0.84
The biological behavior of primary cerebral neuroblastoma: a reappraisal of the clinical course in a series of 70 cases. Ann Neurol (1984) 0.83
Transbilayer disposition of the phospholipid annulus surrounding a calcium transport protein. Nature (1978) 0.83
Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia. Stroke (1997) 0.83
Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Exp Neurol (2001) 0.83
Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion. Eur J Pharmacol (1980) 0.83
Amino acids as central nervous transmitters: biochemical studies. Neurosci Res (N Y) (1973) 0.83
Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism. Exp Neurol (1994) 0.82
A case of epignathus with long term survival. Br J Plast Surg (1970) 0.82
Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Biochem Biophys Res Commun (1999) 0.82
Acute renal failure in burns. Scand J Plast Reconstr Surg (1979) 0.81
NMDA receptors increase OH radicals in vivo by using nitric oxide synthase and protein kinase C. Neuroreport (1993) 0.81
Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase. Neuroreport (1994) 0.81
Gastric myoelectrical activity in patients with Parkinson's disease: evidence of a primary gastric abnormality. Dig Dis Sci (1999) 0.81
A postsynaptic GABA transporter in rat spinal motor neurones. Neurosci Lett (1992) 0.81
MPP+ induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid. Brain Res (1998) 0.80
Alterations in neurotransmitter amino acids in hippocampal kindled seizures. Epilepsy Res (1989) 0.80
Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry (1979) 0.80
The cervix and its secretion in mammals. Physiol Rev (1968) 0.79
Distribution of mRNA for the GABA transporter GAT-1 in the rat brain: evidence that GABA uptake is not limited to presynaptic neurons. J Anat (1994) 0.79
Evidence for a chronic loss of inhibition in the hippocampus after kindling: biochemical studies. Epilepsy Res (1989) 0.79
Inhibitors of GABA metabolism: implications for Huntington's disease. Ann Neurol (1977) 0.79
Mechanism of antifertility action of low doses of alpha-chlorohydrin in the male rat. J Reprod Fertil (1974) 0.78
Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function. Synapse (1994) 0.78
Mechanisms of antifertility action of chlormadinone acetate in the rabbit. Biol Reprod (1969) 0.78
Development of striatal dopaminergic function. II: Dopaminergic regulation of transcription of the immediate early gene zif268 and of D1 (D1a) and D2 (D2a) receptors during pre- and postnatal development. Brain Res Dev Brain Res (1996) 0.78
Are neurotransmitter carriers cell-specific markers? Trends Neurosci (1992) 0.78